Hainan Shuangcheng Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Hainan Shuangcheng Pharmaceuticals has a total shareholder equity of CN¥503.7M and total debt of CN¥165.6M, which brings its debt-to-equity ratio to 32.9%. Its total assets and total liabilities are CN¥798.5M and CN¥294.8M respectively.
Key information
32.9%
Debt to equity ratio
CN¥165.59m
Debt
Interest coverage ratio | n/a |
Cash | CN¥25.80m |
Equity | CN¥503.68m |
Total liabilities | CN¥294.77m |
Total assets | CN¥798.46m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002693's short term assets (CN¥131.1M) exceed its short term liabilities (CN¥129.2M).
Long Term Liabilities: 002693's short term assets (CN¥131.1M) do not cover its long term liabilities (CN¥165.5M).
Debt to Equity History and Analysis
Debt Level: 002693's net debt to equity ratio (27.8%) is considered satisfactory.
Reducing Debt: 002693's debt to equity ratio has increased from 28.5% to 32.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 002693 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 002693 has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 22.6% each year.